FindTrial
Sign In

COVID SECOND WAVE

Ocular sequelae of second wave of COVID-19 - COVID SEQUELAE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/033949
Enrollment
116
Registered
2021-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Severe COVID-19 recovered patients (https://www.mohfw.gov.in/pdf/UpdatedClinicalManagementProtocolforCOVID19dated03072020.pdf) patients Treated at LN hospital, New Delhi At least 2 weeks after discharge Naso-pharyngeal swab RT-PCR negative ï?· 18 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Presence of Ocular finding related to COVID-19Timepoint: 2 weeks—

Secondary

MeasureTime frame
Presence of ocular finding related to COVID therapyTimepoint: 15.06.21 to 31.07.21—

Countries

India

Contacts

Public ContactRitu Arora

Maulana Azad Medical College

dr_rituarora@yahoo.com9968604331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026